{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:34:28Z","timestamp":1765233268751,"version":"3.37.3"},"reference-count":34,"publisher":"Georg Thieme Verlag KG","issue":"08","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thorac Cardiovasc Surg"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Background\u2003Transcatheter aortic valve replacement (TAVR) for a degenerated surgical bioprosthesis (valve-in-valve [ViV]) has become an established procedure. Elevated gradients and patient-prosthesis mismatch (PPM) have previously been reported in mixed TAVR cohorts. We analyzed our single-center experience using the third-generation self-expanding Medtronic Evolut R prosthesis, with an emphasis on the incidence and outcomes of PPM.<\/jats:p><jats:p>\n          Methods\u2003This is a retrospective analysis of prospectively collected data from our TAVR database. Intraprocedural and intrahospital outcomes are reported.<\/jats:p><jats:p>\n          Results\u2003Eighty-six patients underwent ViV-TAVR with the Evolut R prosthesis. Mean age was 75.5\u2009\u00b1\u20099.5 years, 64% were males. The mean log EuroScore was 21.6\u2009\u00b1\u200915.7%. The mean time between initial surgical valve implantation and ViV-TAVR was 8.8\u2009\u00b1\u20093.2 years. The mean true internal diameter of the implanted surgical valves was 20.9\u2009\u00b1\u20092.2\u2009mm. Post-AVR, 60% had no PPM, 34% had moderate PPM, and 6% had severe PPM. After ViV-TAVR, 33% had no PPM, 29% had moderate, and 39% had severe PPM. After implantation, the mean transvalvular gradient was reduced significantly from 36.4\u2009\u00b1\u200915.2 to 15.5\u2009\u00b1\u20099.1\u2009mm Hg (p\u2009&lt;\u20090.001). No patient had more than mild aortic regurgitation after ViV-TAVR. No conversion to surgery was necessary. Estimated Kaplan\u2013Meier survival at 1 year for all patients was 87.4%. One-year survival showed no significant difference according to post-ViV PPM groups (p\u2009=\u20090.356).<\/jats:p><jats:p>\n          Conclusion\u2003ViV-TAVR using a supra-annular valve resulted in low procedural and in-hospital complication rates. However, moderate or severe PPM was common, with no influence on short-term survival. PPM may not be a suitable factor to predict survival after ViV-TAVR.<\/jats:p>","DOI":"10.1055\/s-0042-1742755","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:25:18Z","timestamp":1646699118000},"page":"632-640","source":"Crossref","is-referenced-by-count":1,"title":["Incidence of Prosthesis-Patient Mismatch in Valve-in-Valve with a Supra-Annular Valve"],"prefix":"10.1055","volume":"71","author":[{"given":"Louhai","family":"Alwan","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, German Heart Centre Munich, Munchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik","family":"Ruge","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, German Heart Centre Munich, Munchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Krane","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Department of Surgery, Yale University School of Medicine, New Haven, CT, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatol","family":"Prinzing","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, German Heart Centre Munich, Munchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Noebauer","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, German Heart Centre Munich, Munchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00fcdiger","family":"Lange","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, German Heart Centre Munich, Munchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7560-9257","authenticated-orcid":false,"given":"Magdalena","family":"Erlebach","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, German Heart Centre Munich, Munchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,3,7]]},"reference":[{"issue":"05","key":"ref1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.176857","article-title":"ACC\/AHA 2006 guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease)","volume":"114","author":"R O Bonow","year":"2006","journal-title":"Circulation"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jtcvs.2008.08.015","article-title":"Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database","volume":"137","author":"J M Brown","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"05","key":"ref3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1054-8807(03)00075-9","article-title":"The evolution of bioprosthetic heart valve design and its impact on durability","volume":"12","author":"I Vesely","year":"2003","journal-title":"Cardiovasc Pathol"},{"issue":"02","key":"ref4","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.athoracsur.2013.03.032","article-title":"Carpentier-Edwards pericardial valve in the aortic position: 25-years experience","volume":"96","author":"J Forcillo","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jacc.2004.01.053","article-title":"Durability of pericardial versus porcine aortic valves","volume":"44","author":"G Gao","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"09","key":"ref6","first-page":"1494","article-title":"Redo aortic valve surgery versus transcatheter valve-in-valve implantation for failing surgical bioprosthetic valves: consecutive patients in a single-center setting","volume":"7","author":"M Erlebach","year":"2015","journal-title":"J Thorac Dis"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jacc.2009.12.014","article-title":"Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience","volume":"55","author":"J Rod\u00e9s-Cabau","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.athoracsur.2008.09.030","article-title":"Redo valvular surgery in elderly patients","volume":"87","author":"M Maganti","year":"2009","journal-title":"Ann Thorac Surg"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.athoracsur.2010.04.057","article-title":"Reoperative valve surgery in the elderly: predictors of risk and long-term survival","volume":"90","author":"L B Balsam","year":"2010","journal-title":"Ann Thorac Surg"},{"issue":"06","key":"ref10","first-page":"991","article-title":"The risk of reoperative heart valve procedures in octogenarian patients","volume":"13","author":"M Kirsch","year":"2004","journal-title":"J Heart Valve Dis"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jacc.2009.06.060","article-title":"Transcatheter aortic valve implantation for stenosed and regurgitant aortic valve bioprostheses CoreValve for failed bioprosthetic aortic valve replacements","volume":"55","author":"M Z Khawaja","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"07","key":"ref12","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jcin.2011.03.016","article-title":"Transcatheter aortic valve implantation for failing surgical aortic bioprosthetic valve: from concept to clinical application and evaluation (part 1)","volume":"4","author":"N Piazza","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jcin.2011.07.015","article-title":"Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves","volume":"4","author":"H Eggebrecht","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/heartjnl-2017-312422","article-title":"Incidence, predictors and clinical outcomes of residual stenosis after aortic valve-in-valve","volume":"104","author":"S Bleiziffer","year":"2018","journal-title":"Heart"},{"issue":"29","key":"ref15","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/eurheartj\/ehaa544","article-title":"Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves","volume":"41","author":"S Bleiziffer","year":"2020","journal-title":"Eur Heart J"},{"issue":"15","key":"ref16","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jacc.2012.09.001","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document","volume":"60","author":"A P Kappetein","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"06","key":"ref17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/ehjci\/jew025","article-title":"Recommendations for the imaging assessment of prosthetic heart valves: a report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular Imaging","volume":"17","author":"P Lancellotti","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"07","key":"ref18","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/CIRCULATIONAHA.108.778886","article-title":"Prosthetic heart valves: selection of the optimal prosthesis and long-term management","volume":"119","author":"P Pibarot","year":"2009","journal-title":"Circulation"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0895-4356(95)00048-8","article-title":"Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates","volume":"48","author":"P Peduzzi","year":"1995","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jcin.2019.02.029","article-title":"TAVR for failed surgical aortic bioprostheses using a self-expanding device: 1-year results from the prospective VIVA postmarket study","volume":"12","author":"D Tch\u00e9tch\u00e9","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"18","key":"ref21","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.jacc.2017.02.057","article-title":"Transcatheter aortic valve implantation within degenerated aortic surgical bioprostheses: PARTNER 2 valve-in-valve registry","volume":"69","author":"J G Webb","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"ref22","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/CIRCULATIONAHA.112.104505","article-title":"Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry","volume":"126","author":"D Dvir","year":"2012","journal-title":"Circulation"},{"issue":"08","key":"ref23","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/eurheartj\/ehx455","article-title":"Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry","volume":"39","author":"H B Ribeiro","year":"2018","journal-title":"Eur Heart J"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"e002079","DOI":"10.1161\/CIRCINTERVENTIONS.114.002079","article-title":"Coronary obstruction in transcatheter aortic valve-in-valve implantation: preprocedural evaluation, device selection, protection, and treatment","volume":"8","author":"D Dvir","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"issue":"06","key":"ref25","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jcin.2020.01.227","article-title":"Chimney stenting for coronary occlusion during TAVR: insights from the Chimney Registry","volume":"13","author":"F Mercanti","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"07","key":"ref26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jcin.2018.01.247","article-title":"Transcatheter laceration of aortic leaflets to prevent coronary obstruction during transcatheter aortic valve replacement: concept to first-in-human","volume":"11","author":"J M Khan","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"09","key":"ref27","doi-asserted-by":"crossref","first-page":"e1026","DOI":"10.4244\/EIJ-D-17-00245","article-title":"Fracturing mechanics before valve-in-valve therapy of small aortic bioprosthetic heart valves","volume":"13","author":"P Johansen","year":"2017","journal-title":"EuroIntervention"},{"issue":"05","key":"ref28","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.athoracsur.2017.04.007","article-title":"Bioprosthetic valve fracture to facilitate transcatheter valve-in-valve implantation","volume":"104","author":"K B Allen","year":"2017","journal-title":"Ann Thorac Surg"},{"issue":"07","key":"ref29","doi-asserted-by":"crossref","first-page":"e005216","DOI":"10.1161\/CIRCINTERVENTIONS.117.005216","article-title":"Bioprosthetic valve fracture improves the hemodynamic results of valve-in-valve transcatheter aortic valve replacement","volume":"10","author":"A K Chhatriwalla","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"issue":"02","key":"ref30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/24748706.2019.1704102","article-title":"Bioprosthetic valve remodeling of trifecta surgical valves to facilitate valve-in-valve TAVR","volume":"4","author":"J T Saxon","year":"2020","journal-title":"Struct Heart"},{"issue":"06","key":"ref31","doi-asserted-by":"crossref","first-page":"e003651","DOI":"10.1161\/CIRCINTERVENTIONS.115.003651","article-title":"Transcatheter replacement of failed bioprosthetic valves: large multicenter assessment of the effect of implantation depth on hemodynamics after aortic valve-in-valve","volume":"9","author":"M Simonato","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/eurheartj\/ehs003","article-title":"The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27 186 patients with 133 141 patient-years","volume":"33","author":"S J Head","year":"2012","journal-title":"Eur Heart J"},{"issue":"18","key":"ref33","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.jcin.2021.07.015","article-title":"Surgical explantation after TAVR failure: mid-term outcomes from the EXPLANT-TAVR international registry","volume":"14","author":"V N Bapat","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"13","key":"ref34","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jcin.2020.04.029","article-title":"Reoperation after transcatheter aortic valve replacement: an analysis of the Society of Thoracic Surgeons Database","volume":"13","author":"O K Jawitz","year":"2020","journal-title":"JACC Cardiovasc Interv"}],"container-title":["The Thoracic and Cardiovascular Surgeon"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0042-1742755.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T23:45:48Z","timestamp":1701733548000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0042-1742755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,7]]},"references-count":34,"journal-issue":{"issue":"08","published-online":{"date-parts":[[2023,12,4]]},"published-print":{"date-parts":[[2023,12]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0042-1742755","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0171-6425","1439-1902"],"issn-type":[{"type":"print","value":"0171-6425"},{"type":"electronic","value":"1439-1902"}],"subject":[],"published":{"date-parts":[[2022,3,7]]}}}